PancreaSolve

PancreaSolve

PancreaSolve™ provides technology and services towards accelerating drug development using an integrative platform for quantitative modeling of complex molecular pathways. The platform uses in-silico modeling to bridge in-vitro testing with human clinical trials with the goal of eliminating animal experimentation. PancreaSolve™ is built on the foundation of Computational biology, a field that is in rapid transition from diagrammatic representation of pathways to quantitative and predictive mathematical models, which span time-scales, knowledge domains and spatial-scales. This transition is being accelerated by high-throughput experimentation which isolates reactions and their corresponding rate constants.